Atherosclerosis-related biomarkers in women with endometriosis: The effects of dienogest and oral contraceptive therapy

This publication has 29 references indexed in Scilit:

• Endometriosis and Risk of Coronary Heart Disease
  Circulation: Cardiovascular Quality and Outcomes, 2016
• Evaluation of oxidative stress markers and intra-extracellular antioxidant activities in patients with endometriosis
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 2016
• Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 2015
• The Effect of Low-dose Combined Oral Contraceptive Pills on Brachial Artery Endothelial Function and Common Carotid Artery Intima–Media Thickness
  Journal of Stroke and Cerebrovascular Diseases, 2014
• Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness
  Integrated Blood Pressure Control, 2013
• Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study
  Human Reproduction, 2012
• Oral contraceptive therapy increases oxidative stress in pre-menopausal women
  International Journal of Preventive Medicine, 2012
• Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial
  Human Reproduction, 2010
• Measurable serum markers of oxidative stress response in women with endometriosis
  Fertility and Sterility, 2009
• Derivatives of Reactive Oxygen Metabolites Correlates with High-Sensitivity C-Reactive Protein
  Journal of Atherosclerosis and Thrombosis, 2008